News from wuxi pharmatech (cayman) inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 15, 2014, 08:00 ET

WuXi Opening Offices in Boston and San Francisco

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the...

Nov 12, 2014, 16:30 ET

WuXi PharmaTech Announces Third-Quarter 2014 Results

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Nov 12, 2014, 08:00 ET

WuXi AppTec Announces Enhanced Genomics Services for Chinese Researchers

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the...

Nov 11, 2014, 10:23 ET

WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2014 Annual General Meeting

WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong...

Oct 22, 2014, 08:00 ET

Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China

CAMBRIDGE, Mass. and SHANGHAI, Oct. 22, 2014 /PRNewswire/--  Foundation Medicine, Inc. (NASDAQ:FMI) and WuXi PharmaTech (Cayman) Inc....

Oct 21, 2014, 07:51 ET

WuXi PharmaTech Schedules Third-Quarter 2014 Earnings Release

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...

Jul 22, 2014, 08:00 ET

WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in...

Jul 08, 2014, 16:30 ET

Director Ying Han Resigns from WuXi Board

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in...

Jun 20, 2014, 08:00 ET

WuXi PharmaTech Toxicology Facility in Suzhou Passes FDA Inspection

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations...

May 28, 2014, 08:00 ET

WuXi PharmaTech Begins Operation of New High-Potency API Laboratory

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in...

May 14, 2014, 16:30 ET

WuXi PharmaTech Announces First-Quarter 2014 Results

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development services company serving the pharmaceutical, biotechnology, and...

May 13, 2014, 08:00 ET

WuXi PharmaTech Completes Construction of New Biosafety Testing Facility in Suzhou

 WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations...

May 12, 2014, 08:00 ET

WuXi PharmaTech Completes Construction of New Materials Characterization Facility in St. Paul

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in...

May 08, 2014, 08:26 ET

WuXi PharmaTech Begins Construction of New R&D and cGMP Manufacturing Campus in Changzhou

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development (R&D) services...

May 05, 2014, 08:00 ET

FDA Approves Ibalizumab Manufactured by WuXi PharmaTech for Treatment of Patients on Expanded Access

WuXi PharmaTech (NYSE: WX) and TaiMed Biologics today announced that the FDA has approved the first batch of the ibalizumab (TMB-355) drug...

May 01, 2014, 08:00 ET

WuXi PharmaTech Receives 2013 Lilly Global Supplier Award

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with...

Apr 30, 2014, 08:00 ET

WuXi PharmaTech Facilities for Late- and Commercial-Stage Analytical and Stability Testing and Clinical-Trial Materials Manufacturing Pass FDA Audit

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with...

Apr 29, 2014, 08:23 ET

WuXi PharmaTech Breaks Ground on New Cell Therapy Manufacturing Facility

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in...

Apr 22, 2014, 07:39 ET

WuXi PharmaTech Schedules First-Quarter 2014 Earnings Release

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company with operations...

Apr 01, 2014, 08:00 ET

WuXi PharmaTech Corporate Venture Fund Invests in TruTag Security Platform for Drug Safety

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in...